Drugs for Tremor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 94)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-3-Isobutyl GABA
(S+)-3-isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-isobutyl GABA
3-Isobutyl gaba
3-Isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
|
CI-1008
CID5486971
D02716
DB00230
FT-0080911
GABA, 3-isobutyl
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregabalina
Pregablin
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
|
|
2 |
|
Memantine |
Approved, Investigational |
Phase 4 |
|
19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
19982-08-2
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-dimethyladamantan-1-amine
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
Axura
BBL000737
Biomol-NT_000209
BPBio1_001117
BPBio1_001270
BSPBio_001015
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DivK1c_000068
DMAA
Ebixa
EU-0053634
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
KBio2_006223
|
KBio3_001926
KBioGR_001543
KBioSS_001087
Lopac0_000861
LS-157051
Lundbeck brand OF memantine hydrochloride
Memantin
Memantina
Memantina [INN-Spanish]
memantine
Memantine
Memantine (INN)
Memantine [INN:BAN]
Memantine [INN]
Memantine HCL
Memantine hydrochloride
Memantine Hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
MolPort-002-041-858
Namenda
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
Spectrum_000607
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
ST057652
STK520682
UNII-W8O17SJF3T
ZERO/006024
|
|
3 |
|
Rotigotine |
Approved |
Phase 4 |
|
99755-59-6, 92206-54-7 |
57537 |
Synonyms:
(+)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol
(+--)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol
(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol
2-(N-N-Propyl-N-2-thienylethylamino)-5-hydroxytetralin
N 0437, (-)-Isomer
N 0437, (+-)-Isomer
N 0437, (R)-Isomer
N 0437, Hydrochloride, (R)-isomer
|
N 0437, Hydrochloride, (S)-isomer
Neupro
Racemic N-0437
Rotigotina
Rotigotine
Rotigotine (+-)-form
Rotigotine CDS
|
|
4 |
|
Gabapentin |
Approved, Investigational |
Phase 4 |
|
60142-96-3 |
3446 |
Synonyms:
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
1-(Aminomethyl)-cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
Aclonium
AKOS000280865
Apo gabapentin
Apo-gabapentin
ApoGabapentin
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
Convalis
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G0318
G-154
G154_SIGMA
Gabapen
gabapentin
Gabapentin
Gabapentin (JAN/USAN/INN)
gabapentin (Neurontin)
Gabapentin [USAN:INN:BAN]
Gabapentin GR
Gabapentin hexal
Gabapentin Hexal
Gabapentin ratiopharm
Gabapentin stada
Gabapentin Stada
gabapentina
Gabapentina
Gabapentine
Gabapentine [INN-French]
gabapentinium
Gabapentino
|
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GBN
Go 3450
GOE 2450
Goe-3450
Gralise
Hexal brand of gabapentin
HMS1570N03
HMS2089J03
HSDB 7364
I06-0677
L000733
Lopac0_000582
Lopac-G-154
LS-7194
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
Neurontin
Neurontin (TN)
Novo gabapentin
Novo-gabapentin
NovoGabapentin
Novo-Gabapentin
Novo-gabapentine
Novopharm brand of gabapentin
NSC742194
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
PMS-Gabapentin
Prestwick_151
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
ratiopharm brand of gabapentin
S2133_Selleck
Serada
SMR000058311
SPBio_002822
Stadapharm brand of gabapentin
STK598009
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
|
|
5 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
|
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
6 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
445643 439492 6473866 |
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
Advagraf
AKOS005145901
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
Anhydrous, tacrolimus
BCBcMAP01_000194
Bio-0921
Bio2_000470
Bio2_000950
BRD-K35452788-001-02-1
BSPBio_001279
BSPBio-001279
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
Cilag brand OF tacrolimus
CPD000466356
CPD-10016
D08556
DB00864
DivK1c_001040
FK 506
FK5
Fk-506
FK506
FK-506
FR 900506
FR900506
|
FR-900506
FT-0082660
Fujimycin
Fujisawa brand OF tacrolimus
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
Janssen brand OF tacrolimus
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
nchembio.2007.23-comp2
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Prograft
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
tacrolimus
Tacrolimus
Tacrolimus (anhydrous)
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus anhydrous
tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
|
|
7 |
|
Imidazole |
Experimental, Investigational |
Phase 4 |
|
288-32-4 |
795 |
Synonyms:
{Pyrro[b]monazole}
1,3-Diaza-2,4-cyclopentadiene
1,3-Diazole
1H-Imidazole
Al-imidazole
Cu-imidazole
Glyoxalin
Glyoxaline
Him
IMD
Imidazol
Imidazole
Imidazole acetate
|
Imidazole citrate
Imidazole conjugate monoacid
Imidazole monohydrochloride
Imidazole monophosphonate
Imidazole sodium
Imidazolium chloride
Iminazole
Imutex
Miazole
N,N'-1,2-ethenediylmethanimidamide
N,N'-vinyleneformamidine
Pyrro(b)monazole
Pyrro[b]monazole
|
|
8 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
9 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
10 |
|
Hormones |
|
Phase 4 |
|
|
|
11 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
12 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
13 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
14 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
15 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
16 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
17 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
18 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
19 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
20 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
21 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
22 |
|
Immunosuppressive Agents |
|
Phase 4 |
|
|
|
23 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
24 |
|
Calcineurin Inhibitors |
|
Phase 4 |
|
|
|
25 |
|
Topiramate |
Approved |
Phase 3 |
|
97240-79-4 |
5284627 |
Synonyms:
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
Cilag brand of topiramate
CPD000466325
D00537
DB00273
-D-fructopyranose deriv.
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
|
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
McN 4853
McN-4853
MCN-4853
MLS000759431
MLS001424070
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
Ortho brand of topiramate
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
Spectrum2_001128
STOCK1N-71037
T0575_SIGMA
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
TL8006021
Topamac
Topamax
Topamax (TN)
Topamax sprinkle
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
topiramate
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
topiramatum [Latin]
Topiramic acid
Topomax
TOR
TPM
Trokendi XR
UNII-0H73WJJ391
USL-255
|
|
26 |
|
tannic acid |
Approved |
Phase 3 |
|
1401-55-4 |
|
Synonyms:
ácido tánico
Gallotannic acid
|
|
|
27 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
28 |
|
Sodium oxybate |
Approved |
Phase 2, Phase 3 |
|
502-85-2 |
5360545 |
Synonyms:
4-Hydroxybuttersaeure natriumsalz
4-Hydroxybutyrate sodium
4-Hydroxybutyric acid monosodium salt
4-Hydroxybutyric acid sodium salt
502-85-2
Anetamin
ARONIS24196
Butanoic acid, 4-hydroxy-, monosodium salt
Butanoic acid, 4-hydroxy-, sodium salt
Butanoic acid, 4-hydroxy-, sodium salt (1:1)
Butyric acid, 4-hydroxy-, monosodium salt
Butyric acid, 4-hydroxy-, monosodium salt (8CI)
BUTYRIC ACID, 4-HYDROXY-, SODIUM SALT
C4H7O3.Na
CHEMBL1200682
CID10412
D05866
EB 27
EINECS 207-953-3
Gamma OH
gamma-Hydroxy sodium butyrate
gamma-Hydroxybutyrate sodium
gamma-Hydroxybutyrate sodium salt
gamma-Hydroxybutyric acid sodium salt
gamma-Hydroxybutyric acid, sodium salt
GHB
|
H3635_SIGMA
H-4040
HMS2091E15
Hydroxybutyric acid monosodium salt
LS-48077
MolPort-001-766-711
MolPort-006-717-541
Natrium 4-hydroxybutyrat
NSC 84223
OR28769
Oxybate sodium
Sodium 4-hydroxybutyrate
Sodium gammahydroxybutyrate
Sodium gamma-hydroxybutyrate
Sodium oxybate
Sodium oxybate (USAN)
Sodium Oxybate [USAN]
Sodium Oxybutyrate
Sodium-4-hydroxybutyrate
Somsanit
UNII-7G33012534
WY 3478
WY-3478
Xyrem
Xyrem (TN)
|
|
29 |
|
Dopamine |
Approved |
Phase 3 |
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
Hydroxytyramin
|
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
30 |
|
Ethanol |
Approved |
Phase 2, Phase 3 |
|
64-17-5 |
702 |
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
31 |
|
Hypoglycemic Agents |
|
Phase 3 |
|
|
|
32 |
|
Carbidopa, levodopa drug combination |
|
Phase 3 |
|
|
|
33 |
|
Anesthetics |
|
Phase 2, Phase 3 |
|
|
|
34 |
|
Anesthetics, Intravenous |
|
Phase 2, Phase 3 |
|
|
|
35 |
|
Anesthetics, General |
|
Phase 2, Phase 3 |
|
|
|
36 |
|
Antipsychotic Agents |
|
Phase 3 |
|
|
|
37 |
|
Levetiracetam |
Approved |
Phase 1, Phase 2 |
|
102767-28-2 |
441341 |
Synonyms:
(-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
102767-28-2
AC-1479
AC1NR4PY
alpha Ethyl 2 oxo 1 pyrrolidineacetamide
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
BIDD:GT0242
C8H14N2O2
CHEMBL1286
CID5284583
CPD000466303
e Keppra
Etiracetam
Etiracetam levo-isomer
Etiracetam, R isomer
Etiracetam, R-isomer
Etiracetam, S isomer
etiracetam, S-isomer
Etiracetam, S-isomer
FT-0082600
HMS2051D07
HMS2089L20
Keppra
Keppra XR
Keppra, Keppra XR),Levetiracetam
L-059
levetiracetam
Levetiracetam
Levetiracetam [INN]
|
Levetiracetame
Levetiracetamum
Levetiracetamum [INN-Latin]
Levetiractam
Leviteracetam
Levitiracetam
LS-137054
MLS000759403
MLS001424069
MolPort-003-848-377
NCGC00186028-01
R-Isomer etiracetam
S1356_Selleck
SAM001246539
SBB070161
SIB-S1
S-Isomer etiracetam
SMR000466303
TL8000131
Torleva
UCB brand OF levetiracetam
Ucb L059
ucb L060
Ucb L060
UCB-22059
UCB-L 059
Ucb-L059
UCB-L059
UcbL060
Ucb-L060
ZINC01547851
|
|
38 |
|
Dronabinol |
Approved, Illicit |
Phase 1, Phase 2 |
|
1972-08-3 |
16078 |
Synonyms:
&Delta
(-)- delta 9-Tetrahydrocannabinol
(-)-.delta.(sup9)-trans-Tetrahydrocannabinol
(-)-.DELTA.1-Tetrahydrocannabinol
(-)-.DELTA.9-Tetrahydrocannabinol
(-)-.DELTA.9-THC
(-)-.DELTA.9-trans-Tetrahydrocannabinol
(-)-3,4-trans-Delta1-Tetrahydrocannabinol
(-)-delta 1-Tetrahydrocannabinol
(-)-delta 9-THC
(-)-delta 9-trans-Tetrahydrocannabinol
(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol
(-)-delta1-Tetrahydrocannabinol
(-)-delta9-(trans)-Tetrahydrocannabinol
(-)-delta9-Tetrahydrocannabinol
(-)-delta9-trans-Tetrahydrocannabinol
(-)-trans-.DELTA.9-Tetrahydrocannabinol
(-)-trans-delta 1-Tetrahydrocannabinol
(-)-trans-delta 9-Tetrahydrocannabinol
(-)-trans-delta 9-THC
(-)-trans-Delta1-Tetrahydrocannabinol
(-)-trans-delta9-Tetrahydrocannabinol
(-)-trans-Delta9-THC
(-)-Δ9-trans-tetrahydrocannabinol
(L)-.delta.1-Tetrahydrocannabinol
(L)-delta 1-Tetrahydrocannabinol
(l)-delta(sup 1)-Tetrahydrocannabinol
(l)-delta1-Tetrahydrocannabinol
.delta.(sup9)-THC
.DELTA.1-Tetrahydrocannabinol
.DELTA.1-THC
.delta.-9-THC
.DELTA.9-THC
.DELTA.9-trans-Tetrahydrocannabinol
1363-19-5
14146-29-3
14146-43-1
14C-.DELTA.1-Tetrahydrocannabinol
14C-delta 1-Tetrahydrocannabinol
1972-08-3
1-trans-.delta.(sup9)-tetrahydrocannabinol
1-trans-D9-Tetrahydrocannabinol
1-trans-delta 9-Tetrahydrocannabinol
1-trans-delta(sup 9)-Tetrahydrocannabinol
1-trans-delta(sup9)-tetrahydrocannabinol
1-trans-delta9-Tetrahydrocannabinol
1-trans-delta-9-Tetrahydrocannabinol
1-trans-Δ-9-tetrahydrocannabinol
26108-45-2
308064-99-5
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol
5957-27-7
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
6465-30-1
6H-Dibenzo
9 Ene tetrahydrocannabinol
9-delta-Tetrahydrocannabinol
9-ene-Tetrahydrocannabinol
9-Ene-tetrahydrocannabinol
9-tetrahydrocannabinol
9-THC
Abbott 40566
AC1L277U
AC1Q2VRZ
BIDD:GT0427
C06972
Cannabinol, Delta1-tetrahydro- (7CI)
Cannabinol, tetrahydro- (6CI)
Cannabis resin
CAT-310
CCRIS 4726
CHEBI:104496
CHEMBL465
CID16078
Compassia
D00306
DB00470
Dea No. 7369
DEA No. 7369
Dea No. 7370
DEA No. 7370
delta 1-Tetrahydrocannabinol
delta 1-THC
delta 9-Tetrahydrocannabinol
delta 9-THC
delta 9-trans-Tetrahydrocannabinol
delta(1)-tetrahydrocannabinol
delta(1)-Tetrahydrocannabinol
Delta(1)-Tetrahydrocannabinol
delta(1)-THC
delta(9)-Tetrahydrocannabinol
delta(9)-Tetrahydrocannibinol
delta(9)-THC
Delta(9)-THC
delta(sup 1)-Tetrahydrocannabinol
delta(sup 1)-Thc
|
delta(sup 9)-Tetrahydrocannabinol
delta(sup 9)-Thc
delta1-Tetrahydrocannabinol
delta1-Tetrahydrocannabinol (VAN)
delta1-THC
delta9-tetrahydrocannabinol
delta-9-tetrahydrocannabinol
delta9-Tetrahydrocannabinol
DELTA-9-TETRAHYDROCANNABINOL
delta9-Tetrahydrocannabinol (VAN)
Delta9-Tetrahydrocannabinol solution
delta9-THC
delta-9-THC
DELTA-9-THC
delta9-trans-Tetrahydrocannabinol
Deltanyne
delta-THC
DRG-0138
Drona binol
Dronabinol
Dronabinol (USP/INN)
Dronabinol [Usan:Inn]
Dronabinol [USAN:INN]
Dronabinolum
Dronabinolum [Latin]
EPA 28
EPA-PLUS
Exocyclic delta (9)(11)-tetrahydrocannabiol
Fats and Glyceridic oils, fish, n-3 fatty acid-high
Fish oils, n-3 fatty acid-high
Fish oils, omega-3 fatty acid-high
Ganja
Hashish
HSDB 6471
L-.delta.1-Tetrahydrocannabinol
L-.delta.1-trans-Tetrahydrocannabinol
L-delta 1-trans-Tetrahydrocannabinol
L-delta(sup 1)-tetrahydrocannabinol
L-delta1-trans-Tetrahydrocannabinol
LS-975
L-trans-.delta.9-Tetrahydrocannabinol
L-trans-delta 9-Tetrahydrocannabinol
L-trans-delta9-Tetrahydrocannabinol
Marincap
Marinol
Marinol (TN)
MaxEPA
MolPort-003-959-698
Namisol
nchembio.129-comp1
nchembio.552-comp1
nchembio.86-comp3
NSC 134454
NSC134454
omega-3-Fatty acid
Omegaven
PDSP2_000714
Primolut
Promega
Pro-Mega
QCD 84924
QCD-84924
Relivar
Solvay brand OF tetrahydrocannabinol
Sonergx
SP 104
Syndros
T2386_SIGMA
T4764_FLUKA
T4764_SIGMA
Tetrahydrocannabinol
TETRAHYDROCANNABINOL
Tetrahydrocannabinol delta9
Tetrahydrocannabinol, (6ar-cis)-isomer
Tetrahydrocannabinol, (6as-cis)-isomer
Tetrahydrocannabinol, (6a-trans)-isomer
Tetrahydrocannabinol, trans isomer
Tetrahydrocannabinol, trans-(+-)-isomer
Tetrahydrocannabinol, trans-isomer
Tetrahydrocannabinols (-)-delta1-3,4-trans-form
Tetranabinex
THC
THC-delta-9
trans-.DELTA.9-Tetrahydrocannabinol
trans-delta (-)-9-Tetrahydrocannabinol
trans-delta 9-Tetrahydrocannabinol
trans-delta9-Tetrahydrocannabinol
trans-delta-9-Tetrahydrocannabinol
trans-tetrahydrocannabinol
UNII-7J8897W37S
ZINC01530625
Δ(1)-tetrahydrocannabinol
Δ(9)-THC
Δ9-tetrahydrocannabinol
Δ-9-tetrahydrocannabinol
Δ-9-THC
|
|
39 |
|
Strawberry |
Approved |
Phase 2 |
|
|
|
40 |
|
Progesterone |
Approved, Vet_approved |
Phase 2 |
|
57-83-0 |
5994 |
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17alpha-progesterone
17alpha-Progesterone
17a-Progesterone
17α-progesterone
17Α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
46665_FLUKA
46665_RIEDEL
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC1L1LKF
AC-700
Agolutin
AI3-51682
Akrolutin
Amen
BB_NC-0185
beta-Progesterone
BHR-100
BIDD:ER0547
BIDD:PXR0094
Bio-luton
Bio-Luton
bmse000482
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
Colprosterone
component of Cyclogesterin
Corlutin
Corlutina
Corluvite
Corporin
corpus luteum hormone
Corpus luteum hormone
Corpus Luteum Hormone
CPD000058345
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
Cycrin
D00066
D4-Pregnene-3,20-dione
DB00396
Delalutin
delta(4)-Pregnene-3,20-dione
Delta(4)-pregnene-3,20-dione
Delta(4)-Pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta4-Pregnene-3,20-dione
DR-2011
Duraprogen
EINECS 200-350-6
Endometrin
Estima
ETI-411
EU-0100895
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gelbkörperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
Hormoflaveine
Hormoluton
HSDB 3389
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
Lingusorbs
Lipolutin
Lipo-lutin
Lipo-Lutin
LMST02030159
Lopac0_000895
LS-234
Lucorteum
Lucorteum sol
Lucorteum Sol
Lugesteron
Luteal hormone
Luteal Hormone
Luteinique
Luteocrin normale
Luteocrin Normale
Luteodyn
Luteogan
luteohormone
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
|
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin m
Lutocuclin M
Lutocyclin
Lutocyclin m
Lutocyclin M
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
Membrettes
Methylpregnone
Micronized Progesterone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MolPort-001-794-643
MPA
Nalutron
Natural Progesterone
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
nchembio.2007.53-comp14
NCI60_042166
NSC 64377
NSC 9704
NSC64377
NSC9704
NSC-9704
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
Percutacrine
Percutacrine luteinique
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick_411
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
PROGESTERONE
Progestérone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
Progesterone, water-soluble
Progesterone: HBC complex
Progesterone-Water Soluble
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
Spectrum5_002053
SR-01000000088
SR-01000000088-5
Syngesterone
Syngestrets
Synovex S
Syntolutan
Thiuram E
Thiuranide
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
Δ(4)-pregnene-3,20-dione
|
|
41 |
|
Propranolol |
Approved, Investigational |
Phase 2 |
|
525-66-6 |
4946 |
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
13013-17-7
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
AY 64043
AY-20694
Bedranol
Beprane
Berkolol
Beta Neg
Betachron
Betadren
Betalong
Beta-Neg
beta-Propranolol
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
BPBio1_001040
b-Propranolol
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
C07407
C16H21NO2
Cardinol
Caridolol
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
cMAP_000071
Corpendol
D,L-Propranolol
D08443
DB00571
Deralin
Dexpropranolol
DivK1c_000023
Dl-Propranolol Hydrochloride
DL-Propranolol hydrochloride
Dociton
Duranol
Efektolol
EINECS 208-378-0
EINECS 235-867-6
Elbrol
etalong
Etalong
Euprovasin
Frekven
Herzbase
HMS2090L21
Hydrochloride, propranolol
ICI 45520
IDI1_000023
Ikopal
Inderal
Inderal hydrochloride
Inderal La
Inderalici
Inderex
Inderide
INDERIDE-40/25
INDERIDE-80/25
|
Inderol
Indobloc
Innopran XL
InnoPranXL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
Lopac0_000896
LS-122410
LS-184129
Migrastat
MolPort-001-794-623
Naprilin
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Pranolol
Prano-Puren
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
propranolol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol [INN:BAN]
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol hydrochloride
Propranolol Hydrochloride
propranololo
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor line
Reducor Line
Rexigen
Sagittol
Sawatal
Servanolol
Sloprolol
SPBio_001361
SPBio_001658
SPBio_003093
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
STK735510
Sumial
Tesnol
UNII-9Y8NXQ24VQ
β-Propranolol
Β-propranolol
|
|
42 |
|
Levodopa |
Approved |
Phase 2 |
|
59-92-7 |
6047 |
Synonyms:
(-)-(3,4-Dihydroxyphenyl)alanine
(−)-3-(3,4-dihydroxyphenyl)-L-alanine
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(−)-dopa
(-)-Dopa
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
.Beta.-(3, 4-Dihydroxyphenyl)alanine
.Beta.-(3,4-Dihydroxyphenyl)-L-alanine
1E83F927-C221-46AA-B90A-81B33C5F3868
23734-74-9
25525-15-9
2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
3 Hydroxy L tyrosine
3-(3,4-Dihydroxypheny
3-(3,4-Dihydroxyphenyl)-L-alanine
3, 4-Dihydroxy-L-phenylalanine
3, 4-Dihydroxyphenylalanine
3,4-dihydroxy-L-phenylalanine
3,4-Dihydroxy-L-phenylalanine
3,4-dihydroxyphenylalanine
3,4-Dihydroxyphenylalanine
3,4-DIHYDROXYPHENYLALANINE
3,4-Dihydroxyphenylalanine (VAN)
3,4-Dihydroxyphenyl-L-alanine
34241-25-3
37830_FLUKA
3-Hydroxy-L-tyrosine
587-45-1
59-92-7
72572-99-7
72573-00-3
88250-23-1
90638-38-3
AC-11686
AC1L1LOR
AC1Q4U7F
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
b-(3,4-Dihydroxyphenyl)-L-alanine
Bendopa
beta-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
BIDD:GT0158
Bio-0575
Biodopa
bmse000322
BPBio1_000059
Brocadopa
BSPBio_000053
BSPBio_002354
C00355
C9H11NO4
CAS-59-92-7
CCRIS 3766
Cerepap
CHEBI:15765
CHEMBL1009
CID6047
Cidandopa
component of Sinemet
D 9628
D00059
D0600
D9628
D9628_SIGMA
DAH
DB01235
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
DivK1c_000452
Dopa
DOPA
Dopaflex
Dopaidan
Dopal
Dopal-fher
Dopal-Fher
Dopalina
Dopar
Dopar (TN)
Doparkine
Doparl
Dopasol
Dopaston
Dopaston SE
Dopastone
Dopastral
Dopicar
Doprin
EINECS 200-445-2
Eldopal
Eldopar
Eldopatec
EU-0100454
Eurodopa
Helfo DOPA
Helfo-dopa
|
Helfo-Dopa
HMS1568C15
HMS1922J14
HMS2090O08
HMS2093N04
HMS501G14
HSDB 3348
IDI1_000452
InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14
Insulamina
IV Levodopa
KBio1_000452
KBio2_000934
KBio2_003502
KBio2_006070
KBioGR_001177
KBioSS_000934
L 3,4 Dihydroxyphenylalanine
L Dopa
L(-)-Dopa
L-(-)-Dopa
L-(3, 4-Dihydroxyphenyl)-.alpha.-alani
L-(3, 4-Dihydroxyphenyl)alanine
L-(o-Dihydroxyphenyl)alanine
l)-L-alanine
L-.Beta.-(3,4-Dihydroxyphenyl)alanine
L-3-(3,4-Dihydroxyphenyl)alanine
L-3-(3,4-Dihydroxyphenyl)-alanine
L-3,4-dihydroxyphenylalanine
L-3,4-Dihydroxyphenylalanine
L-3-Hydroxytyrosine
L-4-5-Dihydroxyphenylalanine
Laradopa
Larodopa
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-b-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-Dihydroxyphenylalanine
L-DOPA
L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa
Ledopa
Levedopa
Levodopa
Levodopa (JP15/USP)
Levodopa (JP15/USP/INN)
Levodopa [USAN:INN:BAN:JAN]
Levodopum
Levodopum [INN-Latin]
Levopa
L-O-Dihydroxyphenylalanine
L-o-Hydroxytyrosine
Lopac0_000454
Lopac-D-9628
LS-255
L-Β-(3,4-dihydroxyphenyl)alanine
Maipedopa
Medphano brand OF levodopa
MLS000028514
MolPort-000-856-937
NCGC00015384-01
NCGC00016270-01
NCGC00016270-06
NCGC00093869-04
nchembio.2007.55-comp26
nchembio.89-comp9
ne
NINDS_000452
NSC 118381
NSC118381
Parda
Pardopa
PDSP1_001541
PDSP2_001525
Prestwick_185
Prestwick0_000017
Prestwick1_000017
Prestwick2_000017
Prestwick3_000017
Prodopa
Ro 4-6316
Roberts brand OF levodopa
Roche brand OF levodopa
S1726_Selleck
SDCCGMLS-0066924.P001
SMR000058312
Sobiodopa
SPBio_000391
SPBio_001974
Spectrum_000454
Spectrum2_000496
SPECTRUM2300205
Spectrum4_000539
Spectrum5_001899
Syndopa
UNII-46627O600J
Veldopa
Weldopa
β-(3,4-dihydroxyphenyl)alanine
Β-(3,4-dihydroxyphenyl)alanine
β-(3,4-dihydroxyphenyl)-L-alanine
Β-(3,4-dihydroxyphenyl)-L-alanine
|
|
43 |
|
Sage |
Approved |
Phase 2 |
|
|
|
Synonyms:
sage leaf allergenic extract
|
|
|
44 |
|
Diphenhydramine |
Approved, Investigational |
Phase 2 |
|
147-24-0, 58-73-1 |
3100 |
Synonyms:
147-24-0
147-24-0 (HYDROCHLORIDE)
2-(benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride
2-(diphenylmethoxy)-N,N-dimethylethanamine
2-(Diphenylmethoxy)-N,N-dimethylethylamine
2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine
2-benzhydryloxyethyl-N,N-dimethylammonium
2-benzhydryloxy-N,N-dimethylethanamine
2-diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
2PM
58-73-1
88637-37-0 (citrate (1:1))
a-(2-Dimethylaminoethoxy)diphenylmethane
AB00053460
AC-13704
AC1L1F65
AKOS003658554
Aleryl
Alledryl
Allerdryl
Allergan
Allergan B
Allergeval
Allergical
Allergina
Allergival
Allermax Caplets
Aller-Med
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Amidryl
Antistominum
Antitussive
Antomin
Automin
Bagodryl
Banophen
Banophen Caplets
Baramine
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Beldin
Belix
Bena
Benachlor
Benadrin
Benadryl
Benadryl (hydrochloride)
Benadryl Allergy
BENADRYL HCl
Ben-allergin
Benapon
Bendylate
Benhydramin
Benodin
Benodine
Benylan
Benylin
Benzantin
Benzantine
Benzhydramine
Benzhydraminum
Benzhydril
Benzhydroamina
Benzhydryl
beta-Dimethylamino-aethyl-benzhydryl-aether
beta-Dimethylamino-aethyl-benzhydryl-aether [German]
beta-Dimethylaminoethanol diphenylmethyl ether
beta-dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethyl benzhydryl ether
beta-Dimethylaminoethylbenzhydrylether
Betramin
BIDD:GT0152
BPBio1_000275
BRD-K47278471-003-05-7
BRN 1914136
BSPBio_000249
BSPBio_002219
CAS-147-24-0
CCRIS 1959
CHEBI:127629
CHEBI:4636
CHEMBL657
CID3100
Citrate, diphenhydramine
Compoz
CPD-10890
D00300
Dabylen
DB01075
DB06975
Debendrin
Dermistina
Dermodrin
Desentol
Diabenyl
Diabylen
Dibendrin
Dibenil
Dibondrin
Difedryl
Difenhidramina
Difenhidramina [INN-Spanish]
Difenhydramin
Difenhydramine
Difenidramina
Difenidramina [Italian]
Dihidral
Dimedrol
Dimedrol base
Dimedrolum
Dimedryl
Dimehydrinate
Dimethylamine benzhydryl ester
|
Diphamine
Diphantine
Diphen
Diphen Cough
Diphenhist
Diphenhist Captabs
diphenhydramine
Diphenhydramine
Diphenhydramine (JP15/INN)
Diphenhydramine [INN:BAN:JAN]
Diphenhydramine Base
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine HCl
Diphenhydramine hydrochloride
DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE
Diphenhydraminum
Diphenhydraminum [INN-Latin]
Diphenylhydramin
Diphenylhydramine
DivK1c_000368
Dobacen
Dormarex 2
Dormin
Dryistan
Drylistan
Dylamon
EINECS 200-396-7
Etanautine
FAR 90X2
Genahist
Histaxin
HMS2089E06
HSDB 3066
Hyadrine
Hydramine
Hydrochloride, diphenhydramine
Hyrexin
I14-6749
Ibiodral
IDI1_000368
KBio1_000368
KBio2_001460
KBio2_004028
KBio2_006596
KBio3_001439
KBioGR_001099
KBioSS_001460
L000227
Lopac0_000377
Lopac-D-3630
LS-68208
Medidryl
Mephadryl
MLS002222276
MolPort-001-783-508
N-(2-(diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
N-(Benzhydryloksy-etylo)dwumetyloamina
N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]
N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride
N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
Nausen
NCGC00015335-01
NCGC00015335-02
NCGC00015335-03
NCGC00015335-10
NCGC00024414-03
NCGC00024414-04
nchembio747-comp18
NCI60_002916
NCI60_022782
Nervine Nighttime Sleep-Aid
NINDS_000368
Novamina
NSC665800
Nytol Quickcaps
Nytol Quickgels
O-benzhydryldimethylaminoethanol
O-Benzhydryldimethylaminoethanol
Oprea1_254625
PM 255
Prestwick0_000065
Prestwick1_000065
Prestwick2_000065
Prestwick3_000065
Probedryl
Restamin
Restamin (TN)
Rigidil
S51
Siladryl
Silphen
Sleep-Eze D
Sleep-Eze D Extra Strength
SMR001307259
SPBio_000961
SPBio_002170
Spectrum_000980
Spectrum2_000961
Spectrum3_000400
Spectrum4_000520
Spectrum5_000915
STK103720
STOCK2S-94461
Syntedril
Syntodril
TL8003758
Twilite Caplets
UNII-8GTS82S83M
Unisom Sleepgels Maximum Strength
α-(2-dimethylaminoethoxy)diphenylmethane
Α-(2-dimethylaminoethoxy)diphenylmethane
β-dimethylaminoethanol diphenylmethyl ether
Β-dimethylaminoethanol diphenylmethyl ether
β-dimethylaminoethyl benzhydryl ether
Β-dimethylaminoethyl benzhydryl ether
|
|
45 |
|
Promethazine |
Approved, Investigational |
Phase 2 |
|
60-87-7 |
4927 |
Synonyms:
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
(Dimethylamino-2-propyl-10-phenothiazine hydrochloride
10-(2-(Dimethylamino)-2-methylethyl)phenothiazine
10-(2-(Dimethylamino)propyl)phenothiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(dimethylamino)propyl]phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl- (9CI)
10H-Phenothiazine-10-ethanamine, N,N,alpha-trimethyl-, radical ion(1+)
3277 RP
3389 R.p.
38878-40-9
4182 R.p.
4-27-00-01253 (Beilstein Handbook Reference)
60-87-7
73745-50-3
A-91033
AB00053535
AC-15939
AC1L1J92
Antiallersin
Aprobit
Atosil
Avomine
BPBio1_000744
BRN 0088554
BSPBio_000676
BSPBio_002777
C07404
Camergan
CCRIS 7056
CHEBI:8461
CHEMBL643
CID4927
D00494
DB01069
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
DivK1c_000005
EINECS 200-489-2
Fargan
Fenazil
Fenetazina
Fenetazine
Genphen
Hiberna
Histargan
HMS2089E08
HSDB 3173
Hydrochloride, promethazine
IDI1_000005
Iergigan
InChI=1/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Isophenergan
Isopromethazine
KBio1_000005
KBio2_001348
KBio2_003916
KBio2_006484
KBio3_001997
KBioGR_001697
KBioSS_001348
L000495
Lercigan
Lergigan
Lilly 01516
Lilly 1516
Lopac0_000899
LS-264
Metaryl
MolPort-001-783-684
N-(2'-dimethylamino-2'-methyl)ethylphenothiazine
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,α-trimethyl-10H-phenothiazine-10-ethanamine
N,N,Α-trimethyl-10H-phenothiazine-10-ethanamine
N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
|
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride
NCGC00015817-10
NCGC00089735-02
NCGC00089735-03
NCI60_001878
NCI-C60673
N-Dimethylamino-2-methylethyl thiodiphenylamine
NINDS_000005
NSC 30321
NSC30321
Oprea1_758749
Pelpica
Phargan
Phenargan
Phenergan
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolfen
Pipolphen
Pipolphene
Prestwick0_000888
Prestwick1_000888
Prestwick2_000888
Prestwick3_000888
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Promet
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
promethazine
Promethazine
Promethazine (JAN/INN)
PROMETHAZINE (SEE ALSO PROMETHAZINE HYDROCHLORIDE 58-33-3)
Promethazine [INN:BAN]
Promethazine hydrochloride
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Provigan
Pyrethia
Pyrethiazine
Remsed
Romergan
RP 3277
Rumergan
SKF 1498
SPBio_000799
SPBio_002895
Spectrum_000868
Spectrum2_000840
Spectrum3_001019
Spectrum4_001149
Spectrum5_000977
Tanidil
Thiergan
UNII-FF28EJQ494
Valergine
Vallergine
WLN: T C666 BN ISJ B1Y1&N1&1
WY 509
Zipan-25
|
|
46 |
|
Pregnanolone |
Investigational |
Phase 2 |
|
128-20-1 |
31402 |
Synonyms:
(3a,5b)-3-Hydroxypregnan-20-one
(3alpha,5beta)-3-Hydroxypregnan-20-one
(3Α,5β)-3-hydroxypregnan-20-one
3 alpha Hydroxy 5 beta pregnan 20 one
3 alpha, 5 beta Tetrahydroprogesterone
3 alpha, 5 beta-Tetrahydroprogesterone
3 alpha-Hydroxy-5 beta-pregnan-20-one
3 Hydroxypregnan 20 one
3a-Hydroxy-5b-pregnan-20-one
3a-Hydroxy-5b-pregnane-20-one
3alpha,5beta-Pregnanolone
3alpha,5beta-Tetrahydroprogesterone
3alpha-Hydroxy-20-oxo-5beta-pregnane
3alpha-Hydroxy-5beta,17beta-pregnan-20-one
3alpha-Hydroxy-5beta-pregnan-20-one
3alpha-Hydroxy-5beta-pregnane-20-one
3alpha-Hydroxy-5beta-tetrahydroprogesterone
3-Deoxo-3alpha-hydroxy-5beta-dihydroprogesterone
3-Deoxo-3α-hydroxy-5β-dihydroprogesterone
3-Hydroxypregnan-20-one
3α,5β-Pregnanolone
3α,5β-Tetrahydroprogesterone
|
3α-Hydroxy-20-oxo-5β-pregnane
3α-Hydroxy-5β,17β-pregnan-20-one
3Α-hydroxy-5β-pregnan-20-one
3Α-hydroxy-5β-pregnane-20-one
3α-Hydroxy-5β-tetrahydroprogesterone
5beta-Pregnan-3alpha-ol-20-one
5beta-Pregnane-3alpha-ol-20-one
5β-Pregnan-3α-ol-20-one
5β-Pregnane-3α-ol-20-one
alpha-Hydroxy-5 alpha-pregnan-20-one, 3
beta-Pregnan-20-one, 3 alpha-hydroxy-5
eltanolona
Eltanolona
Eltanolone
Eltanolonum
Pregnan-3alpha-ol-20-one
Pregnan-3a-ol-20-one
Pregnan-3α-ol-20-one
Pregnanolone
Pregnanolone, (3alpha)-isomer
Pregnanolone, (3alpha, 5beta, 17-alpha)-isomer
Pregnanolone, (3alpha,5beta)-isomer
|
|
47 |
|
Soy Bean |
|
Phase 2 |
|
|
|
48 |
|
Olive |
|
Phase 2 |
|
|
|
49 |
|
Epidiolex |
|
Phase 1, Phase 2 |
|
|
|
50 |
|
Pharmaceutical Solutions |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 256)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Multi-site, Double-blind, Randomized, Placebo-controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor |
Completed |
NCT00584376 |
Phase 4 |
Pregabalin;Placebo |
2 |
Effects of Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity (Local Field Potentials) Measured Through Implanted Stimulators |
Completed |
NCT02256319 |
Phase 4 |
Dexmedetomidine;Propofol |
3 |
Propranolol and Botulinum Toxin for Essential Vocal Tremor |
Completed |
NCT02111369 |
Phase 4 |
Propranolol |
4 |
A Pilot Clinical Trial of Memantine for Essential Tremor |
Completed |
NCT00439699 |
Phase 4 |
Memantine |
5 |
A 17 Week, Investigator-initiated, Single-center, Double-blind, Randomized, Placebo-controlled, Cross-over Trial of Pregabalin in Essential Tremor |
Completed |
NCT00646451 |
Phase 4 |
pregabalin;placebo capsules |
6 |
Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response |
Completed |
NCT02495883 |
Phase 4 |
Propranolol |
7 |
A Multicenter, Open-Label, Two-Arm Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management |
Completed |
NCT03103919 |
Phase 4 |
Rotigotine |
8 |
Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Oculopalatal Tremor: a Controled Open-label Study |
Completed |
NCT02466191 |
Phase 4 |
Memantine;Gabapentin |
9 |
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR) |
Completed |
NCT00998660 |
Phase 4 |
|
10 |
A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients |
Recruiting |
NCT03461445 |
Phase 4 |
Envarsus;IR Tacrolimus |
11 |
A Pilot Study of Stable Kidney Transplant Recipients Taking Tacrolimus With CNS Symptoms Switched to Envarsus |
Active, not recruiting |
NCT03270462 |
Phase 4 |
Envarsus XR |
12 |
A Placebo-controlled, Double-blind, Randomized, Cross Over Pilot Study of the Efficacy and Tolerability of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor |
Active, not recruiting |
NCT03136341 |
Phase 4 |
Abobotulinum toxin A |
13 |
Atlas Predicted DBS Settings in Essential Tremor |
Suspended |
NCT02678429 |
Phase 4 |
|
14 |
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in the Treatment of Essential Tremor |
Completed |
NCT00236496 |
Phase 3 |
topiramate |
15 |
CSP #468 Phase II - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease, Phase II |
Completed |
NCT01076452 |
Phase 3 |
|
16 |
CSP #468 Phase I - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease |
Completed |
NCT00056563 |
Phase 3 |
|
17 |
Earlier Versus Later L-Dopa in Parkinson's Disease |
Completed |
NCT00004733 |
Phase 3 |
levodopa |
18 |
Novel Therapies for Essential Tremor |
Completed |
NCT00018564 |
Phase 3 |
treatments for essential tremor |
19 |
The Single Center, Phase III Clinical Trial to Evaluate the Efficacy and the Safety of [18F]FPCIT Positron Emission Tomography in Parkinson's Disease and Essential Tremor Patients |
Completed |
NCT00468078 |
Phase 3 |
F-18 FPCIT |
20 |
Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia: A Randomized Controlled Trial |
Completed |
NCT02384343 |
Phase 3 |
Dexmedetomidine;Normal saline |
21 |
Diaphragmatic Breathing and Heart Rate Variability Training for Improving Hypertension in Fragile X Associated Tremor/Ataxia |
Completed |
NCT03816540 |
Phase 3 |
|
22 |
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO) |
Completed |
NCT01438710 |
Phase 3 |
Prograf;LCP-Tacro |
23 |
Double-Blind, Randomized, Controlled, Cross-over Comparison of Efficacy and Safety of Botulinum Toxin Type A in the Targeted Treatment of Disabling Tremor in Multiple Sclerosis |
Completed |
NCT01018485 |
Phase 3 |
Botulinum Toxin Type A |
24 |
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study |
Recruiting |
NCT02555982 |
Phase 3 |
BOTOX ® 200 Unités;Placebo |
25 |
Bilateral Essential Tremor Treatment With Magnetic Resonance-guided Focused Ultrasound |
Recruiting |
NCT04501484 |
Phase 2, Phase 3 |
|
26 |
Central Mechanisms and Treatment Response of Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor |
Recruiting |
NCT03292458 |
Phase 2, Phase 3 |
Sodium Oxybate |
27 |
A Multicentre, Phase 3, Clinical Study to Compare the Striatal Uptake of a Dopamine Transporter Radioligand, DaTSCAN™ Ioflupane (123I) Injection, After Intravenous Administration to Chinese Patients With a Diagnosis of Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy, or Essential Tremor and to Healthy Controls |
Recruiting |
NCT04193527 |
Phase 3 |
DaTSCAN™ Ioflupane (123I) Injection |
28 |
Bilateral Essential Tremor Treatment With Gamma Knife |
Not yet recruiting |
NCT04748640 |
Phase 2, Phase 3 |
|
29 |
Non-inferiority Study of the Molecular Imaging of Dopamine Transporters Using [123I]-FP/CIT-SPECT and [18F] LBT-999-PET to Distinguish Between Parkinson's Disease and Essential Tremor. |
Not yet recruiting |
NCT04265209 |
Phase 3 |
SPECT;PET |
30 |
A 4 Week, Parallel-Design, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Treatment of Neuroleptic-Induced Tremor: Clinical and Instrumental Ratings of Outcome. |
Terminated |
NCT00533455 |
Phase 3 |
Gabapentin |
31 |
Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor: a Double-blind, Cross-over, Placebo-controlled Multicenter Study |
Withdrawn |
NCT01441284 |
Phase 3 |
pramipexole;placebo |
32 |
Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation |
Withdrawn |
NCT00608231 |
Phase 2, Phase 3 |
Dexmedetomidine Hydrochloride Infusion;Normal Saline |
33 |
An Evaluation of Effectiveness and Toxicity of CyberKnife Based Functional Radiosurgery for Parkinson Disease Patients Suffering From Tremor and Its Implementation in Poland |
Unknown status |
NCT02406105 |
Phase 2 |
CyberKnife |
34 |
A Double-Blind, Cross-Over, Placebo-Controlled Efficacy and Tolerability Study of Perampanel and Essential Tremor |
Unknown status |
NCT02668146 |
Phase 2 |
Perampanel;Placebo |
35 |
Transcranial Static Magnetic Field Stimulation (tSMS) in Essential Tremor |
Unknown status |
NCT03780426 |
Phase 2 |
|
36 |
Randomised Crossover Trial of Deep Brain Stimulation of Differential Posterior Subthalamic Area Regions in Parkinson's Disease and Tremor |
Unknown status |
NCT01945567 |
Phase 2 |
|
37 |
Effects of Octanoic Acid for Treatment of Essential Voice Tremor |
Completed |
NCT01864525 |
Phase 1, Phase 2 |
Octanoic acid;Inactive capsule |
38 |
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Safety, Tolerability and Proof of Concept Study of ST101 for Essential Tremor |
Completed |
NCT01332695 |
Phase 2 |
ST101;Placebo |
39 |
Efficacy of Levetiracetam in Patients With Essential Tremor |
Completed |
NCT00620165 |
Phase 1, Phase 2 |
levetiracetam;placebo |
40 |
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response |
Completed |
NCT01961297 |
Phase 2 |
Sodium oxybate |
41 |
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor |
Completed |
NCT00102596 |
Phase 2 |
1-Octanol |
42 |
Effect of Alcohol on Physiologic and Pathologic Tremors |
Completed |
NCT00001925 |
Phase 2 |
Alcohol |
43 |
Novel Therapies for Essential Tremor - Zonisamide Pilot Study |
Completed |
NCT00223743 |
Phase 2 |
Zonisamide |
44 |
Treatment Efficacy of 1-Octanol Compared to Placebo in Adults With Essential Tremor |
Completed |
NCT00080366 |
Phase 2 |
1-Octanol |
45 |
Multiple-dose, Double-blind, Placebo-controlled, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem) in Subjects With Moderate to Severe Essential Tremor |
Completed |
NCT00598078 |
Phase 2 |
Sodium Oxybate;Sodium Oxybate |
46 |
A Double-Blind, Cross-Over, Placebo- Controlled Efficacy and Tolerability Study of Oral Cannabidiol (CBD) and Tetrahydrocannabinol (THC) for Essential Tremor (ET). |
Completed |
NCT03805750 |
Phase 1, Phase 2 |
CBD/THC;Placebo oral capsule |
47 |
A Randomized, Double Blind, Placebo-Controlled, Crossover, Proof of Concept Study to Evaluate the Effectiveness and Safety of Carisbamate in the Treatment of Essential Tremor |
Completed |
NCT00524056 |
Phase 2 |
Carisbamate;Placebo |
48 |
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of CX-8998 for Essential Tremor |
Completed |
NCT03101241 |
Phase 2 |
CX-8998;Placebo |
49 |
A Double-blind, Placebo-controlled, Two-Period Crossover Proof-of-Concept Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-547 Injection in the Treatment of Patients With Essential Tremor |
Completed |
NCT02277106 |
Phase 2 |
SAGE-547;Placebo |
50 |
Double-Blind, Placebo Controlled Pilot-Study of Octanoic Acid in Essential Tremor |
Completed |
NCT00848172 |
Phase 1, Phase 2 |
Octanoic Acid;Placebo |
|